The CBSE Class 10 Science exam is scheduled for February 25, 2026. Students can access the official syllabus, marking scheme, ...
Johnson & Johnson today announced promising new results from the Phase 1b/2 OrigAMI-4 study evaluating the efficacy and safety of subcutaneous (SC) amivantamab monotherapy in patients with human ...
The harm of plastics on human health is well known, but what about their impact on the people living near the plants that ...
If Approved, BRINSUPRI Would Be the First and Only Treatment in the European Union for Non-Cystic Fibrosis Bronchiectasis ...
Asthma remains a significant health burden in the U.S., with more than 60% of adults continuing to experience frequent symptoms despite the ...
Malay Mail on MSN
Earlier access to new treatments? UMMC opens first-in-human clinical trial unit in Malaysian teaching hospital
Universiti Malaya Medical Centre (UMMC) has reached a new milestone in clinical research with the establishment of its Phase I Unit, which will ...
Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around ...
National medical societies have issued clear pediatric vaccine guidelines. The Infectious Diseases Society has called on ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst research report was published on the Company that explains ...
Non-inferiority trial versus PAXLOVID® assessing safety and efficacy, including rates of disease rebound and incidence of Long COVID development, ...
SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, today announced positive topline results from the BL-B01D1-301 trial. The trial has met one of the dual primary endpoints ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback